UNIGE document Scientific Article - Review
previous document  unige:74388  next document
add to browser collection

The future role of CD4 cell count for monitoring antiretroviral therapy

Ford, Nathan
Meintjes, Graeme
Pozniak, Anton
Bygrave, Helen
Hill, Andrew
Peter, Trevor
Davies, Mary-Ann
Grinsztejn, Beatriz
show hidden authors show all authors [1 - 16]
Published in The Lancet Infectious Diseases. 2015, vol. 15, no. 2, p. 241-7
Abstract For more than two decades, CD4 cell count measurements have been central to understanding HIV disease progression, making important clinical decisions, and monitoring the response to antiretroviral therapy (ART). In well resourced settings, the monitoring of patients on ART has been supported by routine virological monitoring. Viral load monitoring was recommended by WHO in 2013 guidelines as the preferred way to monitor people on ART, and efforts are underway to scale up access in resource-limited settings. Recent studies suggest that in situations where viral load is available and patients are virologically suppressed, long-term CD4 monitoring adds little value and stopping CD4 monitoring will have major cost savings. CD4 cell counts will continue to play an important part in initial decisions around ART initiation and clinical management, particularly for patients presenting late to care, and for treatment monitoring where viral load monitoring is restricted. However, in settings where both CD4 cell counts and viral load testing are routinely available, countries should consider reducing the frequency of CD4 cell counts or not doing routine CD4 monitoring for patients who are stable on ART.
Keywords Anti-Retroviral Agents/therapeutic useAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte Count/utilizationDrug Monitoring/methodsHIV Infections/drug therapyHumans
PMID: 25467647
Full text
Article (Published version) (250 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group VIH/SIDA (930)
(ISO format)
FORD, Nathan et al. The future role of CD4 cell count for monitoring antiretroviral therapy. In: The Lancet Infectious Diseases, 2015, vol. 15, n° 2, p. 241-7. doi: 10.1016/S1473-3099(14)70896-5 https://archive-ouverte.unige.ch/unige:74388

286 hits

0 download


Deposited on : 2015-07-28

Export document
Format :
Citation style :